{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:55:48Z","timestamp":1782258948367,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS069936"],"award-info":[{"award-number":["R01 NS069936"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS082296"],"award-info":[{"award-number":["R01 NS082296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 NS065701"],"award-info":[{"award-number":["U54 NS065701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS040470"],"award-info":[{"award-number":["R01 NS040470"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD053312"],"award-info":[{"award-number":["R01 HD053312"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bachmann-Strauss Dystonia & Parkinson Foundation"},{"DOI":"10.13039\/100008537","name":"Benign Essential Blepharospasm Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008537","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tyler's Hope for a Cure"},{"name":"Emory University Research Council"}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.parkreldis.2014.09.029","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T16:13:13Z","timestamp":1412525593000},"page":"1423-1426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Treatment of myoclonus-dystonia syndrome with tetrabenazine"],"prefix":"10.1016","volume":"20","author":[{"given":"Angelo Y.","family":"Luciano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Jinnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Nance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"LeDoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2014.09.029_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/brain\/aws308","article-title":"SGCE mutations cause psychiatric disorders: clinical and genetic characterization","volume":"136","author":"Peall","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/cge.12059","article-title":"Incomplete nonsense-mediated decay facilitates detection of a multi-exonic deletion mutation in SGCE","volume":"84","author":"Xiao","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.21715","article-title":"Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families","volume":"23","author":"Nardocci","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.25326","article-title":"Surgical treatment of myoclonus dystonia syndrome","volume":"28","author":"Rughani","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib5","first-page":"361","article-title":"The unified myoclonus rating scale","volume":"89","author":"Frucht","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","article-title":"Long-term effects of tetrabenazine in hyperkinetic movement disorders","volume":"48","author":"Jankovic","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.21222","article-title":"Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders","volume":"22","author":"Kenny","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/bmc.2862","article-title":"Liquid chromatography-tandem mass spectrometric assay for the determination of tetrabenazine and its active metabolites in human plasma: a pharmacokinetic study","volume":"27","author":"Derangula","year":"2013","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jb\/mvj138","article-title":"Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice","volume":"140","author":"Yokoi","year":"2006","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ejhg.2010.206","article-title":"SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?","volume":"19","author":"Ritz","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e31827f0798","article-title":"Metabolic changes in DYT11 myoclonus-dystonia","volume":"80","author":"Carbon","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamaneurol.2014.99","article-title":"The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias","volume":"71","author":"Popa","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tics.2013.03.003","article-title":"Cerebellar networks with the cerebral cortex and basal ganglia","volume":"17","author":"Bostan","year":"2013","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(86)91283-7","article-title":"Alterations in the noradrenergic projection to the cerebellum of the dystonic (dt) rat","volume":"366","author":"McKeon","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2014.09.029_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0006-8993(87)90976-0","article-title":"Central adrenergic receptor changes in the inherited noradrenergic hyperinnervated mutant mouse tottering","volume":"418","author":"Levitt","year":"1987","journal-title":"Brain Res"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014003666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014003666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T16:20:31Z","timestamp":1538151631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802014003666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1353802014003666"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.09.029","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of myoclonus-dystonia syndrome with tetrabenazine","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}